SymbolBPTSY
NameBIOPHYTIS SA
SectorUNDEFINED
RegionEurope
Industry-
Address75005 France Sorbonne University - BC 9, Batiment A 4eme etage,
Telephone33 1 44 27 23 00
Fax
Email
Websitehttps://www.biophytis.com/en/
IncorporationFR
Incorporated On2006
Employees
Fiscal Year12/31
Public Since
ExchangesOTC
AuditorGrant Thorton LLP;KPMG LLP - New York, New York, (USA);
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001768946
Description

Biophytis is a clinical-stage biotechnology company specialized in the development of
therapeutics that are aimed at slowing the degenerative processes associated with aging
and improving functional outcomes for patients suffering from age-related diseases,
including severe respiratory failure in patients suffering from COVID-19.

Additional info from OTC:
Biophytis is a clinical-stage biotechnology company specialized in the development of
therapeutics that are aimed at slowing the degenerative processes associated with aging
and improving functional outcomes for patients suffering from age-related diseases,
including severe respiratory failure in patients suffering from COVID-19.

2026-02-27 20:14

BIOPHYTIS SA (BPTSY) Files Form 6-K

Read more
2025-10-30 22:00

30 OCTOBRE 2025

Read more
2025-10-13 05:00

13 OCTOBRE 2025

Read more
2025-09-30 05:00

30 SEPTEMBRE 2025

Read more
2025-09-15 05:00

15 SEPTEMBRE 2025

Read more
2025-09-11 05:00

11 SEPTEMBRE 2025

Read more
2025-09-03 05:00

3 SEPTEMBRE 2025

Read more
2025-09-01 05:00

1er SEPTEMBRE 2025

Read more
2025-08-28 05:13

28 AOÛT 2025

Read more
2025-08-05 05:30

5 AOÛT 2025

Read more